Demographic and Regional Trends of Hypertrophic Cardiomyopathy-Related Mortality in the United States, 1999 to 2019
暂无分享,去创建一个
S. Virani | Haider J. Warraich | Robert W. Ariss | A. Kalra | Salik Nazir | M. Fudim | Mahboob Alam | S. Greene | Xiaoming Jia | A. Wang | Muhammad Shahzeb Khan | Rachel A. Wyand | A. Minhas | Rachel A Wyand | Andrew Wang
[1] M. Sherrid,et al. Disease Expression and Outcomes in Black and White Adults With Hypertrophic Cardiomyopathy , 2021, Journal of the American Heart Association.
[2] M. Khan,et al. Rural-Urban Differences in Mortality From Ischemic Heart Disease, Heart Failure, and Stroke in the United States , 2021, Circulation. Cardiovascular quality and outcomes.
[3] D. Kazi,et al. Rural-Urban Disparities: Diabetes, Hypertension, Heart Disease, and Stroke Mortality Among Black and White Adults, 1999-2018. , 2021, Journal of the American College of Cardiology.
[4] N. Smedira,et al. Characteristics and Outcomes of Elderly Patients With Hypertrophic Cardiomyopathy , 2021, Journal of the American Heart Association.
[5] Matthew W. Martinez,et al. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2020, Circulation.
[6] R. Ferreira,et al. Coronary microvascular dysfunction in hypertrophic cardiomyopathy: Pathophysiology, assessment, and clinical impact , 2020, Microcirculation.
[7] E. Ashley,et al. Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy , 2020, Circulation. Heart failure.
[8] E. Ashley,et al. Association of Race With Disease Expression and Clinical Outcomes Among Patients With Hypertrophic Cardiomyopathy. , 2019, JAMA cardiology.
[9] B. Maron,et al. Impact of Sex on Clinical Course and Survival in the Contemporary Treatment Era for Hypertrophic Cardiomyopathy , 2019, Journal of the American Heart Association.
[10] M. Michels,et al. Sex differences in hypertrophic cardiomyopathy: new insights , 2019, Current opinion in cardiology.
[11] C. Yancy,et al. Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association , 2017, Circulation.
[12] A. Hughes,et al. Mechanisms of Myocardial Ischemia in Hypertrophic Cardiomyopathy , 2016, Journal of the American College of Cardiology.
[13] Deepak L. Bhatt,et al. Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings from the Get With The Guidelines-Heart Failure Program , 2016, Circulation.
[14] M. Maron,et al. Occurrence of Clinically Diagnosed Hypertrophic Cardiomyopathy in the United States. , 2016, The American journal of cardiology.
[15] B. Maron,et al. Hypertrophic Cardiomyopathy in Children, Adolescents, and Young Adults Associated With Low Cardiovascular Mortality With Contemporary Management Strategies , 2016, Circulation.
[16] S. Frisbee,et al. Changes in Cardiovascular Health in the United States, 2003–2011 , 2015, Journal of the American Heart Association.
[17] M. Link,et al. Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies. , 2015, Journal of the American College of Cardiology.
[18] Barry J Maron,et al. New perspectives on the prevalence of hypertrophic cardiomyopathy. , 2015, Journal of the American College of Cardiology.
[19] Barry J Maron,et al. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. , 2014, Journal of the American College of Cardiology.
[20] Deborah D Ingram,et al. 2013 NCHS Urban-Rural Classification Scheme for Counties. , 2014, Vital and health statistics. Series 2, Data evaluation and methods research.
[21] B. Gersh,et al. Survival After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy , 2012, Circulation.
[22] L. Jordaens,et al. Outcome and Complications After Implantable Cardioverter Defibrillator Therapy in Hypertrophic Cardiomyopathy: Systematic Review and Meta-Analysis , 2012, Circulation. Heart failure.
[23] H. Krumholz,et al. Racial disparities in health literacy and access to care among patients with heart failure. , 2011, Journal of cardiac failure.
[24] Udo Sechtem,et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. , 2010, Journal of the American College of Cardiology.
[25] G. Bonsel,et al. Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[26] V. Positano,et al. Usefulness of delayed enhancement by magnetic resonance imaging in hypertrophic cardiomyopathy as a marker of disease and its severity. , 2010, The American journal of cardiology.
[27] M. Sheppard,et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy using cardiovascular magnetic resonance , 2010 .
[28] Barry J Maron,et al. The case for myocardial ischemia in hypertrophic cardiomyopathy. , 2009, Journal of the American College of Cardiology.
[29] A. Tajik,et al. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. , 2005, Journal of the American College of Cardiology.
[30] M. Link,et al. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. , 2005, Journal of the American College of Cardiology.
[31] B. Maron,et al. Clinical course of hypertrophic cardiomyopathy with survival to advanced age. , 2003, Journal of the American College of Cardiology.
[32] G Thiene,et al. Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. , 2000, Human pathology.
[33] H M Rosenberg,et al. Age standardization of death rates: implementation of the year 2000 standard. , 1998, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[34] D. D. Ingram,et al. NCHS urban-rural classification scheme for counties. , 2012, Vital and health statistics. Series 2, Data evaluation and methods research.
[35] Jay J. Shen,et al. Factors underlying racial disparities in hospital care of congestive heart failure. , 2007, Ethnicity & disease.